Review
Published on 20 Feb 2025
Cell surface vimentin: a natural human immune response target for immunotherapy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2025.1552323
Volumes
78 Publications
Volume 5 - 2025
Editorial
Published on 18 Feb 2025
Editorial: Tuberculosis: host immunity, diagnostics and therapeutics
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2025.1568256
- 110 views
Review
Published on 13 Feb 2025
Epigenetic regulation of TDP-43: potential implications for amyotrophic lateral sclerosis
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2025.1530719
- 242 views
Editorial
Published on 11 Feb 2025
Editorial: Neuroinflammatory aspects in neurological disorders
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2025.1557546
- 186 views
Original Research
Accepted on 20 Jan 2025
Identifying biomarkers of hepatic fatty acid metabolism disorder in sevoflurane-induced brain developmental injury by bioinformatics analysis
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2025.1369365
Volume 4 - 2024
Editorial
Published on 09 Jan 2025
Editorial: Gene therapy and genome editing for metabolic liver disorders
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1543685
- 310 views
Brief Research Report
Published on 08 Jan 2025
An artificial transcription factor that activates potent interferon-Îł expression in human Jurkat T Cells
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1492370
- 906 views
Original Research
Published on 06 Jan 2025
Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1487526
- 650 views
Opinion
Published on 27 Nov 2024
Human-specific gene ARHGAP11B—potentially an additional tool in the treatment of neurodegenerative diseases?
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1465647
- 464 views
Hypothesis and Theory
Published on 18 Sep 2024
DeltaRex-G, tumor targeted retrovector encoding a CCNG1 inhibitor, for CAR-T cell therapy induced cytokine release syndrome
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1461151
- 1,026 views
Review
Published on 06 Sep 2024
Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1426454
- 1,859 views
- 1 citation
Editorial
Published on 03 Jul 2024
Editorial: Mitochondrial dysfunction affects mechano-energetic coupling in heart failure
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1433102
- 924 views
Original Research
Published on 29 Apr 2024
Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1389456
- 2,329 views
- 1 citation
Editorial
Published on 27 Feb 2024
Editorial: Celebrating the 200th mendel’s anniversary: gene-targeted diagnostics and therapies for cancer
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1366963
- 1,567 views
Review
Published on 01 Feb 2024
Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1310002
- 8,461 views
- 3 citations
Original Research
Published on 26 Jan 2024
Combined analysis of host IFN-Îł, IL-2 and IP-10 as potential LTBI biomarkers in ESAT-6/CFP-10 stimulated blood
Frontiers in Molecular Medicine
doi 10.3389/fmmed.2024.1345510
- 2,570 views
- 4 citations